A demonstration of inhibition of -sheets in both reactive amyloid, using an in vivo mouse model, and synthetic Alzheimer () amyloid, in vitro (pages 143−148).
REFERENCES
Kisilevsky, R. et al. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates. Nature Medicine1, 143−148 (1995). | PubMed | ISI | ChemPort |
Benson, M.D. in Metabolic Basis of Inherited Disease, (eds. Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.,) 7th edn., 4159−4191 (McGraw Hill, New York, 1994).
McKusick, V.A. Mendelian Inheritance in Man (Johns Hopkins Univ. Press, Baltimore, 1992).
Ghiso, J., Wisniewski, T. & Frangione, B. Unifying features in systematic and cerebral amyloidosis. Mol. Neurobiol.8, 49−64 (1994). | PubMed | ISI | ChemPort |
Mullan, M.J. et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of -amyloid. Nature Genet.1, 345−347 (1992). | PubMed | ISI | ChemPort |
SchellenbertG.D. et al. Genetic linkage evidence for a familial Alzhaimer's Disease Locus on Chromosome 14. Science258, 668−671 (1992). | PubMed |
Corder, E.H. et al. Gene Dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science261, 921−923 (1993). | PubMed | ISI | ChemPort |
Okuizumi, K. et al. ApoE-4 and early-onset Alzheimer's. Nature Genet.7, 10−11 (1994). | PubMed | ISI | ChemPort |
Roses, A.D. Apoliprotein E affects the rate of Alzheimer's diease expression: -amyloid burden is a secondary consequence dependant on apo E genotypes and duration of disease. J. Neuropathol. Exp. Neurol.53, 429−437 (1994). | PubMed | ISI | ChemPort |
Tsuda, T. et al. Are the associations between Alzheimer's disease and polymorphisms in the apolipoprotein E and the apolipoprotein CII gene due to linkage disequilibrium? Ann. Neurol.36, 97−100 (1994). | PubMed | ISI | ChemPort |
Leveugle, B. et al. Binding of heparin sulphate gly-cosaminoglycan to -amyloid peptide: inhibition by potentially therapeutic polysulphated compounds. NeuroReport5, 1389−1392 (1994). | PubMed | ISI | ChemPort |
Caubhey, B. Scrapie-associated PrP acculmulation and agent replication: Effects of sulphated gly-cosaminoglycan analogues. Philosoph. Trans. R. Soc. Land. B. Biol. Sci.343, 399−404 (1994).
Maness, L.M. et al. Passage of human amyloid -protein 1-40 across the murine blood-brain barrier. Life Sci.55, 1643−1650 (1994). | Article | PubMed | ISI | ChemPort |
Higgins, L.S. et al. Transgenic mouse brain histopathology resembles early Alzheimer's diease. Ann. Neurol.35, 598−607 (1994). | PubMed | ISI | ChemPort |
Snow, A.D. et al. An important role for heparin sul-fate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron12, 219−234 (1994). | Article | PubMed | ISI | ChemPort |
-sheets in both reactive amyloid, using an in vivo mouse model, and synthetic Alzheimer (
-amyloid. Nature Genet. 1, 345−347 (1992). | 
4 and early-onset Alzheimer's. Nature Genet. 7, 10−11 (1994). | 
